Compass Therapeutics Inc.

Compass Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-based therapies for cancer treatment. Their scientific approach centers on understanding the intricate interplay between angiogenesis (blood vessel formation), the immune system, and tumor growth. Compass aims to develop therapies that target multiple critical biological pathways involved in the anti-tumor response, including modulation of the microvasculature, induction of a potent immune response, and overcoming tumor-induced immunosuppression. Their pipeline includes a diverse range of novel product candidates, which they plan to develop both as standalone therapies and in combination with other proprietary antibodies.

Founded in 2014 and headquartered in Boston, Massachusetts, Compass Therapeutics leverages its proprietary antibody discovery platforms, StitchMabs™ and common light chain technology, to identify and optimize therapeutic candidates. These platforms enable them to generate highly diverse and functional antibody panels with exceptional speed, allowing for rapid translation into potential treatments. The company is actively involved in clinical trials for its various therapeutic candidates, demonstrating its commitment to advancing its science towards improving patient outcomes in oncology.

Compass Therapeutics offers a flexible work environment that empowers employees to achieve a balance between professional and personal life. They encourage a culture of agility and creativity, with opportunities for professional growth and wellness benefits.

Compass Therapeutics offers a competitive overall compensation package including performance management that supports goal achievement and team development with internal recognition awards. Their benefits include wholistic offerings and supportive reimbursement programs, all-company and individual training programs, a generous health insurance plan with a Health Reimbursement Arrangement covering out-of-pocket costs, a Compass Culture Club that organizes employee-driven events and initiatives, a culture of ownership with every employee holding equity in the company, and an all-company community service day.

Compass Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel antibody-based therapies to treat a variety of human diseases, particularly cancer. They are focused on understanding the relationship between angiogenesis, the immune system, and tumor growth, and their pipeline of product candidates targets critical biological pathways involved in an effective anti-tumor response. They strive to advance their therapies as both standalone treatments and in combination with other proprietary antibodies to improve the lives of patients.

Compass Therapeutics fosters a culture that values teamwork, creativity, and a deep passion for science. They prioritize employee growth and well-being, offering competitive compensation, comprehensive benefits, and opportunities for training and development. Their open and collaborative environment encourages employees to share their unique perspectives and contribute to the company's mission of developing transformative cancer therapies.

Compass Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives. Their core values emphasize community, teamwork, and celebrating individuality, creating a culture that encourages open communication, cross-functional collaboration, and a sense of belonging. They offer competitive compensation and benefits packages, prioritize employee development through training programs, and host employee-driven events and initiatives to build a fulfilling community.